Ten tipped to bid for Fairfax
INVESTORS yesterday backed the Ten Network as a key player in the forthcoming era of media ownership, as private equity also surfaced as a likely post-reform participant.
INVESTORS yesterday backed the Ten Network as a key player in the forthcoming era of media ownership, as private equity also surfaced as a likely post-reform participant.
LEADING drug retailer Sigma Pharmaceuticals has made a $566 million play for struggling rival Australian Pharmaceutical Industries.
A US ban on online gaming would not hurt Australian operations, local companies said today, with internet wagering outfit Ebet saying the laws had given “clarity”.
BAD news from Australian Pharmaceutical Industries did nothing to hurt the company’s share price, which surged 20 per cent yesterday on takeover speculation.
RADIOLOGY and healthcare firm DCA Group has received a $2.7 billion takeover offer from buyout firm CVC Asia Pacific.
MAYNE Pharma shares surged 34 per cent today after the cancer drugs manufacturer recommended that shareholders accept a $2.63 billion takeover bid from United States-based specialty pharmaceuticals firm Hospira Inc.
US healthcare equipment maker Cytyc Corp is reviewing its $497 million bid for Australian medical technology outfit Vision Systems, which was yesterday slapped with a multi-million lawsuit.
MAYNE Pharma appears set to become an acquisition target as shares in the British-based cancer-drug maker were halted at the request of the company following a surge on Monday.
DIAGNOSTICS outfit Symbion Health, Australia’s biggest healthcare company, has made an offer for Primary Health Care’s SDS Pathology.
PRIVATE health insurance payments by the nation’s second-biggest private health fund, MBF, grew by $105 million in the past year as members claimed more for health care.
Original URL: https://www.theaustralian.com.au/author/elizabeth-colman/page/39